YNYangyi Nie

Yangyi Nie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yangyi Nie has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Zhang

    Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

    3 shared publications
  • Yuxiao Lai

    Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China

    3 shared publications
  • Cairong Li

    Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

    2 shared publications
  • Long Li

    Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

    2 shared publications
  • Yuanchi Zhang

    Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

    2 shared publications
  • Yuyang Zhang

    National Innovation Center for Advanced Medical Devices, Shenzhen 518131, China

    2 shared publications

Latest Publications

  • Open Access

    Multifunctional Roles of Magnesium Ions in Modulating Bone Regeneration-Related Cells

    by Xiangcheng Lei, Ruipeng Li, Yangyi Nie, Deju Gao, Wei Zhang, Yuxiao Lai, Cairong Li

    Magnesium ions (Mg2+) play pivotal roles in bone regeneration by regulating the biological functions of multiple bone repair-related cells. However, the effective concentration ranges and optimal concentration of Mg2+ for different cell types remain incompletely defined, which limits the precise design of Mg-containing biomaterials with controllable ion release for repairing of bone defects. In this study, the concentration-dependent effects of Mg2+ on the biological functions of bone regeneration-related cells were systematically investigated. Human bone marrow mesenchymal stem cells (hBMSCs), human umbilical vein endothelial cells (HUVECs), rat Schwann cells (RSCs), and RAW264.7 macrophage were selected to evaluate the effective concentration of Mg2+ for promoting osteogenesis, angiogenesis, neuroregulation, and immunomodulation, respectively. The results demonstrated that Mg2+ concentrations ranging from to 16 mM, particularly 8 mM, significantly upregulated the expression of M2 macrophage-related markers, thereby promoting the polarization of RAW264.7 macrophages toward the anti-inflammatory M2 phenotype. Moreover, Mg2+ concentrations between 2 and 8 mM effectively enhanced the osteogenic activity of hBMSCs, the angiogenic activity of HUVECs, and the neuroregulatory function of RSCs, as confirmed by immunofluorescence staining and quantitative PCR analysis of osteogenic, angiogenic, and neuroregulation-related marker expression. These findings provide a comprehensive understanding of the concentration-dependent biological effects of Mg2+ on bone regeneration-related cells and establish a theoretical basis for the rational design of next-generation Mg2+-releasing biomaterials with precise biological regulation.

  • Open Access

    Design and Fabrication of Low-Temperature 3D-Printed Bioactive Polyurethane/MnO2 Scaffolds for Bone Repair

    by Long Li, Along Guo, Yangyi Nie, Zili Xu, Junjie Deng, Yuyang Zhang, Zhenyu Yao, Wei Zhang, Yuxiao Lai, Yuanchi Zhang

    Bone defect repair presents a significant clinical challenge, especially for critical-sized defects, due to the limitation of conventional 3D-printed scaffolds to provide simultaneous mechanical support and bioactivity. Herein, this study developed a bioactive composite scaffold through a low-temperature rapid prototyping (LT-RP) 3D printing technology. The scaffold comprises a polyurethane (PU) matrix enhanced with bioactive manganese dioxide (MnO2) nanoparticles, combining structural integrity with versatile bioactivity for bone repair. By incorporating 2, 6-pyridinedimethanol (PDM) into the PU molecular network, a coordination system is formed, enabling homogeneous distribution and structural integration of MnO2 nanoparticles. As designed, the bioactive scaffolds are fabricated through LT-RP 3D printing technology with a regular porous architecture for improving cell growth. With 10 wt% MnO2, the scaffolds (PPM10) have optimal comprehensive properties, with a modulus of ~14.1 MPa, improved thermal stability, good cytocompatibility, and enhanced osteogenic differentiation. Furthermore, in vitro degradation tests revealed the responsive release of Mn2+ from the PPM10 scaffolds in a glutathione-rich microenvironment. This functionality indicates the potential of the scaffolds to modify the tumor microenvironment for ultimate bone regeneration after bone tumor surgery.


  • Open Access

    Exosomes Derived from Mg-Preconditioned Bone Mesenchymal Stem Cells Promote Angiogenesis and Osteogenesis for Osteonecrosis Treatment

    by Long Li, Luyao Cheng, Yuhan Du, Yuyang Zhang, Zetao Wang, Yangyi Nie, Jing Long, Cairong Li, Yuanchi Zhang, Yuxiao Lai, et al.

    Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory orthopedic disorder, often resulting from prolonged or high-dose glucocorticoid use that impairs bone repair and vascularization. The critical impact of exosomes derived from bone mesenchymal stem cells (BMSCs) in bone regeneration has drawn increasing attention. In this study, we developed a novel type of exosomes derived from Magnesium-preconditioned BMSCs (Mg-Exos) and evaluated their therapeutic potential. In vitro experiments demonstrated that Mg-Exos effectively counteracted Dex-induced impairment in the angiogenic function of human umbilical vein endothelial cells (HUVECs) and the osteogenic differentiation of BMSCs. These findings highlight the promise of Mg-Exos as a potential cell-free therapeutic strategy for SONFH, acting through the concurrent enhancement of vascularization and bone formation. Consequently, this work lays a solid foundation for the future application of Mg-Exos in treating SONFH.